Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$43.2M |
| 2 |
Booking.com
BKNG
|
+$32.2M |
| 3 |
RTX Corp
RTX
|
+$32.1M |
| 4 |
Pfizer
PFE
|
+$30.2M |
| 5 |
Northrop Grumman
NOC
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.3M |
| 2 |
IBM
IBM
|
+$43.1M |
| 3 |
Lowe's Companies
LOW
|
+$36M |
| 4 |
Linde
LIN
|
+$29.1M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$27.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.23% |
| 2 | Technology | 15.76% |
| 3 | Healthcare | 12.99% |
| 4 | Consumer Discretionary | 12.18% |
| 5 | Consumer Staples | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.51T
| $95.4M | 1.75% |
1,300,112
-388,128
| -23% | -$25M |
|
2
Bristol-Myers Squibb
BMY
$137B
| $61.9M | 1.14% |
964,463
-60,747
| -6% | -$3.48M |
|
3
CVS Health
CVS
$119B
| $57.5M | 1.06% |
774,165
+85,363
| +12% | +$5.99M |
|
4
Cisco
CSCO
$438B
| $56.9M | 1.04% |
1,185,387
-95,616
| -7% | -$4.44M |
|
5
AT&T
T
$173B
| $55.3M | 1.01% |
1,872,802
-226,828
| -11% | -$6.55M |
|
|
6
RTX Corp
RTX
$283B
| $51.8M | 0.95% |
549,158
+353,816
| +181% | +$32.1M |
|
7
Chevron
CVX
$403B
| $51.1M | 0.94% |
424,276
+27,108
| +7% | +$3.19M |
|
8
Honeywell
HON
$68.4B
| $50.2M | 0.92% |
300,921
+63,037
| +26% | +$10.3M |
|
9
Lockheed Martin
LMT
$130B
| $47.5M | 0.87% |
121,878
-9,299
| -7% | -$3.57M |
|
10
Biogen
BIIB
$32B
| $47.4M | 0.87% |
159,766
-15,261
| -9% | -$4.23M |
|
11
Microsoft
MSFT
$3.59T
| $47.4M | 0.87% |
300,281
-29,587
| -9% | -$4.35M |
|
12
Verizon
VZ
$205B
| $45.8M | 0.84% |
745,311
+218,902
| +42% | +$13.2M |
|
13
Comcast
CMCSA
$95.3B
| $43.4M | 0.8% |
965,891
+214,954
| +29% | +$9.57M |
|
14
Oracle
ORCL
$422B
| $43.1M | 0.79% |
813,206
-297,694
| -27% | -$16.4M |
|
15
Accenture
ACN
$113B
| $42.9M | 0.79% |
203,622
-75,380
| -27% | -$14.7M |
|
|
16
Phillips 66
PSX
$96.9B
| $42.8M | 0.79% |
+384,100
| New | +$43.2M |
|
17
Walmart Inc
WMT
$825B
| $42.3M | 0.78% |
1,067,064
-22,893
| -2% | -$909K |
|
|
WBA
18
DELISTED
Walgreens Boots Alliance
WBA
| $41.4M | 0.76% |
702,449
-56,262
| -7% | -$3.24M |
|
19
Home Depot
HD
$335B
| $40.5M | 0.74% |
185,315
-92,520
| -33% | -$21M |
|
20
Target
TGT
$75.1B
| $37.9M | 0.7% |
295,545
-55,800
| -16% | -$6.55M |
|
21
Charter Communications
CHTR
$17.9B
| $37.7M | 0.69% |
77,813
+30,229
| +64% | +$13.9M |
|
22
3M
MMM
$92.3B
| $37.1M | 0.68% |
251,574
+71,550
| +40% | +$10M |
|
23
DuPont de Nemours
DD
$18.7B
| $35.8M | 0.66% |
443,997
-70,636
| -14% | -$5.86M |
|
24
Emerson Electric
EMR
$87.7B
| $35.2M | 0.65% |
461,485
+141,520
| +44% | +$10.2M |
|
25
Kraft Heinz
KHC
$30.3B
| $35M | 0.64% |
1,088,949
+299,108
| +38% | +$9.06M |
|
Similar funds
Joel Greenblatt's Q4 2019 Portfolio in Review
As of Q4 2019, Joel Greenblatt held 1,290 positions worth $5.45B, down 3.8% from $5.66B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Joel Greenblatt withdrew a net $632M in Q4 2019, closing 203 positions and reducing 508 holdings. Its most notable exit was Celgene Corp, an estimated $55.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Phillips 66 worth $42.8M.
- Joel Greenblatt's largest Q4 2019 buy was Phillips 66: 384,100 shares worth $42.8M.
- Joel Greenblatt added most to Booking.com in Q4 2019, an estimated $32.2M increase.
- Joel Greenblatt's biggest Q4 2019 reduction was IBM, cutting an estimated $43.1M.
- Joel Greenblatt fully exited Celgene Corp in Q4 2019, selling an estimated $55.3M.
- Joel Greenblatt's ten largest holdings make up 11% of its $5.45B portfolio in Q4 2019.
- Joel Greenblatt opened 215 new positions and closed 203 in Q4 2019.
- Joel Greenblatt's portfolio value fell 3.8% quarter-over-quarter to $5.45B.
Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.